Literature DB >> 22911167

Results of minimally invasive gland-preserving treatment in different types of parotid duct stenosis.

Michael Koch1, Heinrich Iro, Nils Klintworth, Georgios Psychogios, Johannes Zenk.   

Abstract

OBJECTIVE: To assess differences in minimally invasive treatment in various types of Stensen duct stenoses, because sparse data have been published concerning this.
DESIGN: Retrospective study.
SETTING: Tertiary reference center, level of evidence: 2b. PATIENTS: Ninety-three patients with stenoses.
METHODS: Treatment of 111 parotid duct stenoses was evaluated with particular attention to which treatment strategies were successful in various types of stenoses (type 1, inflammatory; type 2, web-associated fibrous; and type 3, fibrous). Minimally invasive treatment consisted of sialendoscopy-guided rinsing with cortisone (all cases) and interventional sialendoscopy with instrumental dilation alone or combined with transoral ductal surgery.
RESULTS: Sialendoscopy-guided rinsing with cortisone was sufficient in 73.0% of cases of type 1 stenosis (21.5% of all cases). Interventional sialendoscopy with instrumental dilation was successful in 47.1% of cases of type 2 stenosis and 70.5% of cases of type 3 stenosis (59.2% of all patients). Interventional sialendoscopy combined with transoral duct surgery was successful in 72.7% of cases of type 3 stenosis (8.6% of all cases). Glands could be preserved in 96.4% of cases.
CONCLUSIONS: Stenoses that can be differentiated using sialendoscopy seem to require different minimally invasive treatment. Sialendoscopy-guided rinsing with cortisone is an important basic anti-inflammatory treatment, particularly in inflammatory stenoses. Interventional sialendoscopy with instrumental dilation, transoral ductal surgery or a combination of both are the first choice in fibrous stenoses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22911167     DOI: 10.1001/archoto.2012.1618

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Intraductal injection as an effective drug delivery route in the management of salivary gland diseases.

Authors:  Chin-Hui Su; Kuo-Sheng Lee; Te-Ming Tseng; How Tseng; Yi-Fang Ding; Michael Koch; Shih-Han Hung
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-09       Impact factor: 2.503

2.  Post-sialendoscopy ductoplasty by salivary duct stent placements.

Authors:  Chin-Hui Su; Kuo-Sheng Lee; Te-Ming Tseng; Shih-Han Hung
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-08       Impact factor: 2.503

3.  Is there a role for ultrasound-guided balloon sialoplasty technique in salivary gland structures.

Authors:  Jimmy Makdissi; Lee Feinberg; Amit Roy
Journal:  Dentomaxillofac Radiol       Date:  2017-10-06       Impact factor: 2.419

4.  Sialendoscopy in treatment of adult chronic recurrent parotitis without sialolithiasis.

Authors:  Johanna Jokela; Aaro Haapaniemi; Antti Mäkitie; Riitta Saarinen
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-30       Impact factor: 2.503

5.  Ultrasound in the diagnosis of parotid duct obstruction not caused by sialolithiasis: diagnostic value in reference to direct visualization with sialendoscopy.

Authors:  Miguel Goncalves; Konstantinos Mantsopoulos; Mirco Schapher; Heinrich Iro; Michael Koch
Journal:  Dentomaxillofac Radiol       Date:  2020-10-08       Impact factor: 2.419

Review 6.  Salivary gland diseases in children.

Authors:  Heinrich Iro; Johannes Zenk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

7.  Design, fabrication, and implantation of tube-shaped devices for the treatment of salivary duct diseases.

Authors:  Diego Velasquez; Laurent Chaunier; Sofiane Guessasma; Frédéric Faure; Alain Bizeau; Graciela Pavon-Djavid; Anne Meddahi-Pellé; Denis Lourdin
Journal:  Bioimpacts       Date:  2017-01-14

Review 8.  Salivary duct stenosis: diagnosis and treatment.

Authors:  M Koch; H Iro
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.